Such efforts may translate efficacious HIF-1α inhibitors into the clinic and uncover new molecular targets in the HIF-1α signaling pathway to increase anticancer efficacy and overcome chemoresistance in gastric cancer treatment. Here, HIF1A is linked to gastric cancer.